Literature DB >> 26508726

Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device.

Alanna A Morris1, Ann Pekarek2, Kris Wittersheim2, Robert T Cole2, Divya Gupta2, Duc Nguyen2, S Raja Laskar2, Javed Butler2, Andrew Smith2, J David Vega2.   

Abstract

BACKGROUND: There is increasing recognition that the risk of stroke after left ventricular assist device (LVAD) implantation varies based on gender, with a higher risk in female patients. We reviewed our own data to determine gender differences in the risk of stroke.
METHODS: Frequency of stroke, including intracranial hemorrhage and ischemic stroke, was retrospectively evaluated in 110 heart failure patients (mean age 49.6 ± 13.6 years, 32% women) discharged from the hospital after implantation of a HeartMate II (N = 74) or HeartWare (N = 36) LVAD. Competing outcomes analysis was used to determine which clinical risk factors were associated with the risk of stroke and death, with the primary end-point being time to first stroke event.
RESULTS: During a median follow-up of 1.3 years, 26 patients had a stroke (23.6%, 0.14 case per person-year). The median time to first stroke was 0.7 (interquartile range 0.3 to 1.4) years. After adjusting for covariates, risk of stroke was higher for women than for men (hazard ratio 3.1, 95% confidence interval 1.4 to 6.9; p = 0.007). There was no difference in overall survival between men and women.
CONCLUSION: The risk of stroke after LVAD varies based on gender, with a higher risk in female patients. More research is needed to fully understand these differences, and whether device management strategies should be tailored based on gender.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  gender; healthcare disparities; heart failure; left ventricular assist device; prognosis; risk factors; stroke

Mesh:

Year:  2015        PMID: 26508726     DOI: 10.1016/j.healun.2015.08.013

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.

Authors:  Deepak Acharya; Renzo Loyaga-Rendon; Charity J Morgan; Kara A Sands; Salpy V Pamboukian; Indranee Rajapreyar; William L Holman; James K Kirklin; José A Tallaj
Journal:  JACC Heart Fail       Date:  2017-10       Impact factor: 12.035

2.  Sex differences in eligibility for advanced heart failure therapies.

Authors:  Rebecca S Steinberg; Aditi Nayak; Celena O'Connell; Sharon Burford; Ann Pekarek; Neile Chesnut; Robert T Cole; Divya Gupta; S Raja Laskar; Kunal Bhatt; Michael Burke; Tamer Attia; Andrew Smith; J David Vega; Alanna A Morris
Journal:  Clin Transplant       Date:  2020-03-16       Impact factor: 2.863

Review 3.  Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.

Authors:  Sung M Cho; Nader Moazami; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

Review 4.  Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.

Authors:  Renzo Y Loyaga-Rendon; Milena Jani; David Fermin; Jennifer K McDermott; Diane Vancamp; Sangjin Lee
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 5.  Sex Differences in the Management of Advanced Heart Failure.

Authors:  Daniela R Crousillat; Nasrien E Ibrahim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-09-21

6.  Sex-Based Heart Transplant Outcomes After Bridging With Centrifugal Left Ventricular Assist Devices.

Authors:  Lauren V Huckaby; Laura M Seese; Edgar Aranda-Michel; Michael A Mathier; Gavin Hickey; Mary E Keebler; Ibrahim Sultan; Thomas G Gleason; Arman Kilic
Journal:  Ann Thorac Surg       Date:  2020-05-04       Impact factor: 4.330

7.  Sex differences in outcomes following less-invasive left ventricular assist device implantation.

Authors:  Silvia Mariani; Tong Li; Karl Bounader; Dietmar Boethig; Alexandra Schöde; Jasmin S Hanke; Jana Michaelis; L Christian Napp; Dominik Berliner; Guenes Dogan; Roberto Lorusso; Axel Haverich; Jan D Schmitto
Journal:  Ann Cardiothorac Surg       Date:  2021-03

8.  Exploring gender differences in trajectories of clinical markers and symptoms after left ventricular assist device implantation.

Authors:  Quin E Denfeld; Kenneth M Faulkner; Mary Roberts Davis; Beth A Habecker; Christopher V Chien; Jill M Gelow; James O Mudd; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2021-10-27       Impact factor: 3.593

Review 9.  Sex-Specific Outcomes in Cardiovascular Device Evaluations.

Authors:  Mohammed Imran Ghare; Daniela Tirziu; Jinnette Dawn Abbott; Elissa Altin; Yiping Yang; Vivian Ng; Cindy Grines; Alexandra Lansky
Journal:  J Womens Health (Larchmt)       Date:  2020-06-15       Impact factor: 3.017

10.  Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department.

Authors:  Davor Milicic; Binyamin Ben Avraham; Ovidiu Chioncel; Yaron D Barac; Eva Goncalvesova; Avishai Grupper; Johann Altenberger; Maria Frigeiro; Arsen Ristic; Nicolaas De Jonge; Steven Tsui; Jacob Lavee; Giuseppe Rosano; Marisa Generosa Crespo-Leiro; Andrew J S Coats; Petar Seferovic; Frank Ruschitzka; Marco Metra; Stefan Anker; Gerasimos Filippatos; Stamatis Adamopoulos; Miriam Abuhazira; Jeremy Elliston; Israel Gotsman; Righab Hamdan; Yoav Hammer; Tal Hasin; Lorrena Hill; Osnat Itzhaki Ben Zadok; Wilfried Mullens; Sanemn Nalbantgil; Massimo Francesco Piepoli; Piotr Ponikowski; Luciano Potena; Arjang Ruhparwar; Aviv Shaul; Laurens F Tops; Stephan Winnik; Tiny Jaarsma; Finn Gustafsson; Tuvia Ben Gal
Journal:  ESC Heart Fail       Date:  2021-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.